Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

CRISPR Therapeutics AG ( NASDAQ: CRSP) H.C. Wainwright 27th Annual Global Investment Conference September 8, 2025 4:30 PM EDT ...

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

VedaBio has entered into agreement with Mammoth Biosciences to enhance its CRISPR-based molecular detection platform for ...

Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...